CALCITRENE Trademark

Trademark Overview

On Tuesday, June 29, 2021, a trademark application was filed for CALCITRENE with the United States Patent and Trademark Office. The USPTO has given the CALCITRENE trademark a serial number of 90801234. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, June 14, 2024. This trademark is owned by Taro Pharmaceuticals U.S.A., Inc.. The CALCITRENE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in dermatology
calcitrene

General Information

Serial Number90801234
Word MarkCALCITRENE
Filing DateTuesday, June 29, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, June 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in dermatology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTaro Pharmaceuticals U.S.A., Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532
Party NameTaro Pharmaceuticals U.S.A., Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHawthorne, NY 10532

Trademark Events

Event DateEvent Description
Friday, July 2, 2021NEW APPLICATION ENTERED
Friday, September 10, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2022ASSIGNED TO EXAMINER
Monday, March 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 1 FILED
Tuesday, December 13, 2022SOU EXTENSION 1 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 16, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 16, 2023SOU EXTENSION 2 FILED
Friday, June 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 3 FILED
Wednesday, December 13, 2023SOU EXTENSION 3 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 14, 2024SOU EXTENSION 4 GRANTED
Friday, June 14, 2024SOU EXTENSION 4 FILED

Related Keywords

calcitrene dermatology preparations pharmaceutical